CryoLife, Inc. (CRY): Price and Financial Metrics


CryoLife, Inc. (CRY)

Today's Latest Price: $23.39 USD

0.81 (3.59%)

Updated Jun 3 3:08pm

Add CRY to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

CRY Stock Summary

  • CRY's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 510.12 -- higher than 92.67% of US-listed equities with positive expected earnings growth.
  • Cryolife Inc's stock had its IPO on February 12, 1993, making it an older stock than 78.17% of US equities in our set.
  • Price to trailing twelve month operating cash flow for CRY is currently 49.26, higher than 94.03% of US stocks with positive operating cash flow.
  • Stocks that are quantitatively similar to CRY, based on their financial statements, market capitalization, and price volatility, are VG, OFIX, AMRN, LIND, and QRHC.
  • Visit CRY's SEC page to see the company's official filings. To visit the company's web site, go to www.cryolife.com.
CRY Daily Price Range
CRY 52-Week Price Range

CRY Stock Price Chart More Charts


CRY Price/Volume Stats

Current price $23.39 52-week high $33.00
Prev. close $22.58 52-week low $12.63
Day low $22.63 Volume 109,039
Day high $23.52 Avg. volume 264,503
50-day MA $20.51 Dividend yield N/A
200-day MA $24.60 Market Cap 882.74M

CryoLife, Inc. (CRY) Company Bio


CryoLife Inc. engages in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac and vascular surgical procedures. The company was founded in 1984 and is based in Kennesaw, Georgia.

CRY Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$23.39$1.18-95%

We started the process of determining a valid price forecast for Cryolife Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Cryolife Inc ranked in the 7th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Cryolife Inc ended up being:

  • The company's compound free cash flow growth rate over the past 5.78 years comes in at -0.03%; that's greater than only 24.7% of US stocks we're applying DCF forecasting to.
  • The company has produced more trailing twelve month cash flow than only 15.31% of its sector Healthcare.
  • Cryolife Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-95%
1%-95%
2%-95%
3%-95%
4%-95%
5%-95%

LHCG, LCTC, CMD, IVC, and PDLI can be thought of as valuation peers to CRY, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


CRY Latest News Stream


Event/TimeNews Detail
Loading, please wait...

CRY Latest Social Stream


Loading social stream, please wait...

View Full CRY Social Stream

Latest CRY News From Around the Web

Below are the latest news stories about Cryolife Inc that investors may wish to consider to help them evaluate CRY as an investment opportunity.

Edited Transcript of CRY earnings conference call or presentation 30-Apr-20 8:30pm GMT

Q1 2020 CryoLife Inc Earnings Call

Yahoo | May 8, 2020

CryoLife (CRY) Q1 2020 Earnings Call Transcript

It is now my pleasure to introduce your host, Lynn Lewis from Gilmartin Group. Joining me today from CryoLife's management team are Pat Mackin, CEO, and Ashley Lee, CFO. Comments made on this call that look forward in time involve risks and uncertainties and are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Yahoo | May 1, 2020

CryoLife Reports First Quarter 2020 Financial Results

ATLANTA, April 30, 2020 /PRNewswire/ -- First Quarter and Recent Business Highlights: Achieved total revenues of $66.4 million in the first quarter 2020 versus preliminary first quarter 2020 revenues of $65.5 million Total revenues decreased 2% and decreased 1% on a constant currency…

PR Newswire | April 30, 2020

CryoLife (CRY) Reports Q1 Loss, Tops Revenue Estimates

CryoLife (CRY) delivered earnings and revenue surprises of -500.00% and 1.26%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research | April 30, 2020

Analysts Estimate CryoLife (CRY) to Report a Decline in Earnings: What to Look Out for

CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | April 23, 2020

Read More 'CRY' Stories Here

CRY Price Returns

1-mo 6.17%
3-mo -6.18%
6-mo -6.29%
1-year -20.71%
3-year 24.75%
5-year 118.65%
YTD -13.66%
2019 -4.55%
2018 48.20%
2017 0.00%
2016 77.64%
2015 -3.76%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.89 seconds.